Literature DB >> 31632812

Expanding the knowledge of oligometastatic disease-but uncertainties remain significant.

Joachim Pfannschmidt1.   

Abstract

Year:  2019        PMID： 31632812      PMCID： PMC6783762          DOI： 10.21037/jtd.2019.06.39

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  18 in total

1.  Metastasis: Spreading the seed.

Authors:  Gemma K Alderton
Journal:  Nat Rev Cancer       Date:  2015-05       Impact factor: 60.716

2.  Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  D Planchard; S Popat; K Kerr; S Novello; E F Smit; C Faivre-Finn; T S Mok; M Reck; P E Van Schil; M D Hellmann; S Peters
Journal:  Ann Oncol       Date:  2018-10-01       Impact factor: 32.976

3.  Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II study.

Authors:  Oscar Arrieta; Feliciano Barrón; Federico Maldonado; Luis Cabrera; José Francisco Corona-Cruz; Monika Blake; Laura Alejandra Ramírez-Tirado; Zyanya Lucia Zatarain-Barrón; Andrés F Cardona; Osvaldo García; Osvaldo Arén; Jaime De la Garza
Journal:  Lung Cancer       Date:  2019-02-07       Impact factor: 5.705

4.  Patterns of Distant Metastases After Surgical Management of Non-Small-cell Lung Cancer.

Authors:  Jordan A Torok; Lin Gu; Daniel J Tandberg; Xiaofei Wang; David H Harpole; Chris R Kelsey; Joseph K Salama
Journal:  Clin Lung Cancer       Date:  2016-07-05       Impact factor: 4.785

5.  Impact of preoperative 18F-FDG PET/CT on survival of resected mono-metastatic non-small cell lung cancer.

Authors:  Simone Tönnies; Mario Tönnies; Jens Kollmeier; Torsten T Bauer; Gregor J Förster; Dirk Kaiser; Klaus-Dieter Wernecke; Joachim Pfannschmidt
Journal:  Lung Cancer       Date:  2015-12-30       Impact factor: 5.705

Review 6.  Oligometastases revisited.

Authors:  Ralph R Weichselbaum; Samuel Hellman
Journal:  Nat Rev Clin Oncol       Date:  2011-03-22       Impact factor: 66.675

7.  Prognostic impact of local treatment against postoperative oligometastases in non-small cell lung cancer.

Authors:  Tokujiro Yano; Akira Haro; Tsukihisa Yoshida; Yosuke Morodomi; Kensaku Ito; Yasunori Shikada; Fumihiro Shoji; Riichiroh Maruyama; Yoshihiko Maehara
Journal:  J Surg Oncol       Date:  2010-12-01       Impact factor: 3.454

8.  Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease.

Authors:  Joseph K Salama; Michael D Hasselle; Steven J Chmura; Renuka Malik; Neil Mehta; Kamil M Yenice; Victoria M Villaflor; Walter M Stadler; Philip C Hoffman; Ezra E W Cohen; Philip P Connell; Daniel J Haraf; Everett E Vokes; Samuel Hellman; Ralph R Weichselbaum
Journal:  Cancer       Date:  2011-10-21       Impact factor: 6.860

Review 9.  Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis.

Authors:  Tawee Tanvetyanon; Lary A Robinson; Michael J Schell; Vivian E Strong; Rachna Kapoor; Daniel G Coit; Gerold Bepler
Journal:  J Clin Oncol       Date:  2008-03-01       Impact factor: 44.544

Review 10.  Abscopal effect of radiotherapy combined with immune checkpoint inhibitors.

Authors:  Yang Liu; Yinping Dong; Li Kong; Fang Shi; Hui Zhu; Jinming Yu
Journal:  J Hematol Oncol       Date:  2018-08-16       Impact factor: 17.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.